Estimating Benefits from Immunesuppressive Treatment in Diffuse Cutaneous Systemic Sclerosis: Data from the Canadian Scleroderma Research Group
Read full paper at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=51274#.VGGiqmfHRK0 Author(s) Tommy Choy 1 , Murray Baron 2 , Janet E. Pope 1,3* Affiliation(s) 1 Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario, Canada . 2 McGill University, Montreal, Canada . 3 Department of Medicine, Division of Rheumatology, St. Joseph’s Health Care, London, Ontario, Canada . ABSTRACT Objective: To determine the efficacy of immunesuppressive treatment over 1 year in early diffuse cutaneous systemic sclerosis (dcSSc). Methods: dcSSc patients with less than 3 years disease duration and at least one year of data enrolled in the CSRG database were included. Regression ...